2. Search Result
Search Result
Results for "

1211443-80-9

" in MedChemExpress (MCE) Product Catalog:

7

Inhibitors & Agonists

2

Isotope-Labeled Compounds

Cat. No. 상품명 Target 연구분야 Chemical Structure
  • HY-15777A
    Ribociclib hydrochloride
    Maximum Cited Publications
    80 Publications Verification

    LEE011 hydrochloride

    		 CDK Neurological Disease Cancer
    RRibociclib (LEE011) hydrochloride is an ATP-competitive and orally active CDK4/6 inhibitor that crosses the blood-brain barrier with IC50 values of 10 nM and 39 nM, respectively, and is over 1,000-fold less potent against the cyclin B/CDK1 complex .
    Ribociclib hydrochloride
  • HY-15777AR
    Ribociclib hydrochloride (Standard)

    LEE011 hydrochloride (Standard)

    		 Reference Standards CDK Cancer
    Ribociclib (Standard) (LEE011(Standard)) hydrochloride is the analytical standard of Ribociclib hydrochloride (HY-15777A). This product is intended for research and analytical applications. Ribociclib hydrochloride (LEE011 hydrochloride) is a highly specific CDK4/6 inhibitor with IC50 values of 10 nM and 39 nM, respectively, and is over 1,000-fold less potent against the cyclin B/CDK1 complex.
    Ribociclib hydrochloride (Standard)
  • HY-15777
    Ribociclib
    Maximum Cited Publications
    80 Publications Verification

    LEE011

    		 CDK Neurological Disease Cancer
    RRibociclib (LEE011) is an ATP-competitive and orally active CDK4/6 inhibitor that crosses the blood-brain barrier with IC50 values of 10 nM and 39 nM, respectively, and is over 1,000-fold less potent against the cyclin B/CDK1 complex .
    Ribociclib
  • HY-15777B
    Ribociclib succinate
    Maximum Cited Publications
    80 Publications Verification

    LEE011 succinate

    		 CDK Neurological Disease Cancer
    RRibociclib (LEE011) succinate is an ATP-competitive and orally active CDK4/6 inhibitor that crosses the blood-brain barrier with IC50 values of 10 nM and 39 nM, respectively, and is over 1,000-fold less potent against the cyclin B/CDK1 complex .
    Ribociclib succinate
  • HY-15777AS
    Ribociclib-d6 hydrochloride

    LEE011-d6 hydrochloride

    		 Isotope-Labeled Compounds CDK Cancer
    Ribociclib-d6 (LEE011-d6) hydrochloride is a deuterium labeled Ribociclib. Ribociclib is a highly specific CDK4/6 inhibitor with IC50 values of 10 nM and 39 nM, respectively, and is over 1,000-fold less potent against the cyclin B/CDK1 complex .
    Ribociclib-d6 hydrochloride
  • HY-15777S
    Ribociclib-d6

    LEE011-d6

    		 CDK Cancer
    Ribociclib-d6 (LEE011-d6) is a deuterium labeled Ribociclib (HY-15777). Ribociclib is a highly specific CDK4/6 inhibitor with IC50 values of 10 nM and 39 nM, respectively, and is over 1,000-fold less potent against the cyclin B/CDK1 complex .
    Ribociclib-d6
  • HY-15777C
    Ribociclib succinate hydrate
    Maximum Cited Publications
    80 Publications Verification

    LEE011 succinate hydrate

    		 CDK Cancer
    RRibociclib (LEE011) succinate hydrate is an ATP-competitive and orally active CDK4/6 inhibitor that crosses the blood-brain barrier with IC50 values of 10 nM and 39 nM, respectively, and is over 1,000-fold less potent against the cyclin B/CDK1 complex .
    Ribociclib succinate hydrate

온라인 문의

Your information is safe with us. * Required Fields.

호칭

  

Country or Region *

고객명 *

 

회사명 *

Department *

     

메일주소 *

 

상품명 *

Cat. No.

  

Requested quantity *

전화번호 *

     

비고

온라인 문의

Inquiry Information

상품명:
Cat. No.:
수량:
MCE Japan Authorized Agent: